Literature DB >> 6095678

Characterization of cholecystokinin receptors on bovine gallbladder membranes.

R W Steigerwalt, I D Goldfine, J A Williams.   

Abstract

Cholecystokinin (CCK) binding to its receptors on a muscularis membrane fraction of bovine gallbladder was characterized using a biologically active CCK-33-[125I]Bolton-Hunter conjugate. Receptor binding was localized to the muscularis layer of the gallbladder; no binding was seen on either mucosal or serosal membranes. At 24 degrees C and pH 6.5, binding was maximal after 60-90 min of incubation, remained at a plateau for at least 240 min, and was reversed by the addition of unlabeled CCK-8. Optimal binding was seen at pH of 5.5 and required the presence of magnesium. Gallbladder binding data, best fit by a two-parameter model using a nonlinear least-squares computer program, was consistent with a single order of binding sites with a Kd of 618 +/- 168 pM and a binding capacity of 100.5 +/- 15.7 fmol/mg prot (mean +/- SE, n = 5). CCK-8 and CCK-33 inhibited 125I-CCK binding to gallbladder membranes with similar potencies, whereas desulfated CCK-8, gastrin I and II, and CCK-4 were at least 500 times less potent than CCK-33. The CCK antagonists dibutyryl cGMP and proglumide inhibited 125I-CCK binding with an IC50 of 31 and 600 microM, respectively. The present studies therefore demonstrate the existence of a specific CCK receptor on bovine gallbladder muscularis membranes with a high degree of selectivity for CCK analogues.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6095678     DOI: 10.1152/ajpgi.1984.247.6.G709

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

1.  Effects of a new cholecystokinin antagonist (GE 410) on the smooth muscle of the guinea pig ileum.

Authors:  A Rakovska; K Milenov; P Henklein
Journal:  Experientia       Date:  1990-10-15

2.  Changes of the ductus hepatocholedochus after gastric stimulant. Results of early functional sonography.

Authors:  P Heistermann; J Buchholz; H Strosche; A Herweg
Journal:  Surg Endosc       Date:  1989       Impact factor: 4.584

3.  Expression of CCK Receptors in Carcinoma Gallbladder and Cholelithiasis: A Pilot Study.

Authors:  Mohammad Shazib Faridi; Mahabir Saran Das Jaiswal; Sudhir K Goel
Journal:  J Clin Diagn Res       Date:  2015-07-01

4.  Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist.

Authors:  R S Chang; V J Lotti
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

5.  Proglumide (gastrin and cholecystokinin receptor antagonist) inhibits insulin secretion in vitro.

Authors:  E J Verspohl; G Wunderle; H P Ammon; J A Williams; I D Goldfine
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-03       Impact factor: 3.000

6.  Cholecystokinin in acute alcoholic and biliary pancreatitis.

Authors:  S Räty; J Sand; E Kemppainen; S Laine; I Nordback
Journal:  Int J Pancreatol       Date:  2000-08

7.  Effects of CCK-receptor antagonists on CCK-stimulated pepsinogen secretion and calcium increase in isolated guinea pig gastric chief cells.

Authors:  C Sakamoto; T Matozaki; H Nishisaki; Y Konda; M Nagao; O Nakano
Journal:  Dig Dis Sci       Date:  1990-07       Impact factor: 3.199

8.  Pathogenesis of the impaired gall bladder contraction of coeliac disease.

Authors:  A M Brown; M J Bradshaw; R Richardson; J G Wheeler; R F Harvey
Journal:  Gut       Date:  1987-11       Impact factor: 23.059

9.  Biliary dyskinesia: is the problem with Oddi?

Authors:  J Wood; A J A Holland; A Shun; H C O Martin
Journal:  Pediatr Surg Int       Date:  2004-02-10       Impact factor: 1.827

10.  Effect of intravenous infusion of proglumide on ruminal motility in conscious sheep (Ovis aries).

Authors:  T Onaga
Journal:  Vet Res Commun       Date:  2007-02-05       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.